政府計畫（GRB），建議「依年度遞減排序」，以查看最新的研究方向。
| 畢業學年度 | 論文標題 | 連結 | 學位 | 畢業時長(年) |
|---|---|---|---|---|
| 關鍵字 | 口試日期 | |||
| 114 | 利用 Mi... 利用 MicroRNA 作為 KRAS 突變胰臟癌的潛在療法 (Using MicroRNAs as the Potential Therapy against KRAS mutated pancreatic cancer) | NTHU NDLTD | 碩 | 1.08 |
. .... | 2025-08-28 | |||
| 114 | 熱休克蛋白... 熱休克蛋白22透過細胞自噬與活性氧調控在肺癌中的保護作用及其對化療抗藥性的影響 (Protective Role of HSP22 in Lung Cancer via Autophagy Activation and ROS Regulation: Implications for Chemoresistance) | NTHU NDLTD | 碩 | 1.03 |
. .... | 2025-08-12 | |||
| 113 | 探討毒胡蘿... 探討毒胡蘿蔔素誘導的內質網壓力增強乳癌細胞中硫化氫介導的代謝調控 (Thapsigargin Induces ER Stress to Enhance Hydrogen Sulfide Mediated Metabolic Reprogramming in Breast Cancer Cells) | NTHU NDLTD | 碩 | 2.00 |
. .... | 2025-07-31 | |||
| 112 | 以 Mic... 以 MicroRNA 針對 KRAS 突變癌症的精準治療 (Precision Therapy Using MicroRNA for Oncogenic KRAS-driven Cancer) | NTHU NDLTD | 碩 | 1.00 |
微小核糖核酸(microRNA)、癌症精準治療(cancer precision therapy)、KRAS(KRAS)、miR502(miR502) 微小核糖核... | 2024-07-30 | |||
| 112 | 探討硫化氫... 探討硫化氫丙酮酸激酶M2硫化的調控及其對腫瘤細胞功能的影響 (The Impact of H2S-mediated S-sulfhydration of PKM2 in Regulating Cancer Cell Oncogenic Functions) | NTHU NDLTD | 碩 | 1.98 |
丙酮酸激酶M2(Pyruvate kinase M2 (PKM2))、硫化氫(Hydrogen sulfide (H2S))、過硫化(S-sulfhydration)、低氧(Hypoxia) 丙酮酸激酶... | 2024-07-23 | |||
| 112 | 硫化氫對丙... 硫化氫對丙酮酸激酶M2活性的分子機制調控 (Endogenous H2S Stimulates Aerobic Glycolysis by Inhibiting the Activity of PKM2) | NTHU NDLTD | 碩 | 2.18 |
硫化氫(Hydrogen Sulfide)、轉譯後修飾(Post-Translational Modification)、硫化(Sulfhydration)、丙酮酸激酶(Pyruvate Kinase)、癌症新陳代謝(Cancer Metabolism) 硫化氫(H... | 2023-10-04 | |||
| 111 | 探討丙酮酸... 探討丙酮酸激酶M2的新穎轉譯後修飾在胞質分裂中的角色 (The Role of The Novel Post-Translational Modification of PKM2 in Cytokinesis) | NTHU NDLTD | 碩 | 0.97 |
三陰性乳癌(Triple-negative breast cancer (TNBC))、丙酮酸激酶M2(Pyruvate kinase isozyme M2 (PKM2))、過硫化(S-sulfhydration (Persulfidation))、胞質分裂(Cytokinesis)、缺氧(Hypoxia) 三陰性乳癌... | 2023-07-19 | |||
| 111 | 鐵硫蛋白D... 鐵硫蛋白Dosmit和HSP22在粒線體生理學中的作用 (The role of iron-sulfur protein Dosmit and HSP22 in mitochondrial physiology) | NTHU NDLTD | 碩 | 1.95 |
粒線體(mitochondria)、鐵硫蛋白(iron-sulfur protein)、熱休克蛋白22(Hsp22)、鐵代謝(iron metabolism)、氧化壓力(oxidative stress) 粒線體(m... | 2023-07-11 | |||
| 110 | 尋找具有潛... 尋找具有潛能的微小核糖核酸用以治療 KRAS 突變引發的癌症 (Identification of therapeutic potential microRNAs to treat KRAS-mutation driven cancers) | NTHU NDLTD | 碩 | 1.99 |
微小核醣核酸(microRNA)、癌症精準治療(cancer precision therapy)、KRAS(KRAS)、致癌基因(oncogene) 微小核醣核... | 2022-07-26 | |||
| 110 | 趨化因子 ... 趨化因子 CXCL7 在乳癌腫瘤微環境中的作用 (The Role of Chemokine CXCL7 in the Breast Tumor Microenvironment) | NTHU NDLTD | 碩 | 1.97 |
趨化因子(Chemokines)、CXCL7(CXCL7)、腫瘤微環境(Tumor microenvironment)、乳癌(Breast cancer) 趨化因子(... | 2022-07-19 | |||
| 110 | 利用去甲基... 利用去甲基化藥物及皮質類固醇促進微核糖核酸708表現做為抑制三陰性乳癌發展及轉移的治療策略 (Hypomethylating agents in combination with glucocorticoids stimulate microRNA-708 expression to treat triple-negative breast cancer) | NTHU NDLTD | 碩 | 0.88 |
乳癌(breast cancer)、表觀遺傳修飾(epigenetic modification)、DNA去甲基化藥物(Decitabine (DAC))、糖皮質激素(Dexamethasone (DEX))、微小核糖核酸708(microRNA-708) 乳癌(br... | 2022-06-16 | |||
| 110 | 針對NRA... 針對NRAS突變癌症開發以微小核糖核酸為基底的精準治療藥物 (MicroRNA-Based Precision Medicine as a Novel Undruggable NRAS Mutant Cancer Therapy) | NTHU NDLTD | 碩 | 0.88 |
MicroRNA-708(MicroRNA-708)、NRAS(NRAS)、標靶治療(Targeted therapy)、黑色素瘤(Melanoma)、白血病(Leukemia) Micro... | 2022-06-16 | |||
| 109 | 粒線體Lo... 粒線體Lon蛋白在腫瘤與樹突細胞中誘導IL-10上升的機制探討 (The mechanisms of IL-10 upregulation by mitochondrial Lon in tumor and dendritic cells) | NTHU NDLTD | 碩 | 1.98 |
介白素10(IL-10)、Lon 蛋白酶(Lon)、樹突細胞(Dendritic cells)、慢性發炎(Chronic inflammation)、腫瘤微環境(Tumor microenvironment) 介白素10... | 2021-07-23 | |||
| 109 | 趨化因子-... 趨化因子- CXCL7在腫瘤微環境下對乳癌細胞和單核球之重要性 (The importance of CXCL7 to breast cancer cells and monocytes in the tumor microenvironment) | NTHU NDLTD | 碩 | 1.98 |
細胞激素(cytokine)、腫瘤微環境(tumor microenvirnment)、趨化因子(chemokine)、乳癌(CXCL7) 細胞激素(... | 2021-07-21 | |||
| 109 | 微小核醣核... 微小核醣核酸-708在黑色素瘤NRAS突變上的治療應用 (Potential therapeutic application of microRNA-708 in NRAS mutated melanoma) | NTHU NDLTD | 碩 | 2.32 |
黑色素瘤(Melanoma)、微小核醣核酸(MAPK pathway)、糖皮質醇(microRNA708) 黑色素瘤(... | 2020-11-24 | |||
| 108 | 阻斷PKM... 阻斷PKM2轉譯後修飾抑制腫瘤生長的分子機制 (Blockage of PKM2 translational modification leads to the inhibition of tumor growth) | NTHU NDLTD | 碩 | 1.98 |
硫化氫(Hydrogen Sulfide)、丙酮酸激酶(Pyruvate Kinase)、糖解作用(Glycolysis)、轉譯後修飾(Post-translation Modifications)、癌症新陳代謝(Cancer Metabolism) 硫化氫(H... | 2020-07-24 | |||
| 107 | Micro... MicroRNA-708啟動子的甲基化促進乳癌的進程與轉移 (Epigenetic suppression of microRNA-708 promotes breast cancer progression and metastasis) | NTHU NDLTD | 碩 | 1.96 |
乳癌(breast cancer)、轉移(metastasis)、表觀遺傳學修飾(epigenetic modifications)、去氧核糖核酸甲基化(DNA methylation)、組蛋白-離氨酸N-甲基轉移酶(EZH2) 乳癌(br... | 2019-07-18 | |||